B Huang

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis · 2012 · 189 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

Bindia Jharap, William J. Sandborn, Walter Reinisch et al. · Alimentary Pharmacology & Therapeutics · 2015 · 82 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · Alimentary Pharmacology & Therapeutics · 2017 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study

Séverine Vermeire, Silvio Danese, Wen Zhou et al. · Journal of Crohn s and Colitis · 2021 · 25 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Caspofungin combined with TMP/SMZ as a first‐line therapy for moderate‐to‐severe PCP in patients with human immunodeficiency virus infection

Qun Tian, Fan Jiang, Ruohao Xu et al. · HIV Medicine · 2020 · 24 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11